MetaVia Inc. (Nasdaq: MTVA), a clinical-stage biotechnology company focused on transforming cardiometabolic diseases, today announced that three late-breaking abstracts highlighting its ...

A new study led by researchers at the UMass Amherst suggests that more than half of type 2 diabetes cases could be prevented ...

Meanwhile in ATTAIN-MAINTAIN, patients who transitioned from injectable semaglutide or tirzepatide to the oral GLP-1 receptor ...

Experts warn about the rising Type-2 diabetes among young Bangladeshis, stressing the impact of unhealthy lifestyles and ...

Primary care practitioners serve a critical role in optimizing clinical outcomes for adults with T2DM by evaluating underlying mechanisms, treatment efficacy, medication safety profiles, and ...

As next-generation GLP-1 contenders rise, key readouts are on the way from Pfizer, Viking Therapeutics and Eli Lilly.

Rochester, N.Y. The Beer Coasters held their annual fundraiser to support the American Diabetes Association.

Americans' household debt continued its steady climb to hit a record $18.8 trillion, according to the New York Fed's ...

Quiz: Which blood tests matter most for aging adults? Most people know they should get blood work done. Fewer know what each ...

Some of the most common diseases that impact our oral health include cavities (tooth decay), gum (periodontal) disease, and oral cancer.

Presentations will feature clinical results for ribupatide, a GLP-1/GIP receptor dual agonist being developed as a ...

A meta-analysis involving more than 43,000 adults with obesity, suggests that obesity medications, such as GLP-1 drugs, could ...